ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.62%
- Poor long term growth as Operating profit has grown by an annual rate 23.75% of over the last 5 years
- The company is Net-Debt Free
2
With ROE of 5.04%, it has a Very Expensive valuation with a 2.14 Price to Book Value
- Over the past year, while the stock has generated a return of 144.53%, its profits have risen by 454.3% ; the PEG ratio of the company is 0.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Biocytogen Pharmaceuticals (Beijing) Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
-100.0%
8.82
83.23%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
36.77%
EBIT Growth (5y)
23.75%
EBIT to Interest (avg)
-2.91
Debt to EBITDA (avg)
0.59
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.49
Tax Ratio
2.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.82%
ROE (avg)
0.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
42
Industry P/E
Price to Book Value
2.14
EV to EBIT
18.89
EV to EBITDA
10.66
EV to Capital Employed
2.84
EV to Sales
2.84
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
15.04%
ROE (Latest)
5.04%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
ROCE(HY)
Highest at 21.82%
NET SALES(Q)
Highest at HKD 1,073.16 MM
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -6.65% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 6.54 times
OPERATING PROFIT(Q)
Highest at HKD 400.82 MM
OPERATING PROFIT MARGIN(Q)
Highest at 37.35 %
PRE-TAX PROFIT(Q)
Highest at HKD 257.47 MM
NET PROFIT(Q)
Highest at HKD 226.95 MM
EPS(Q)
Highest at HKD 0.62
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Pre-Tax Profit
At HKD 257.47 MM has Grown at 394.52%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 226.95 MM has Grown at 635.3%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Net Sales
Highest at HKD 1,073.16 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Net Sales
At HKD 1,073.16 MM has Grown at 60.89%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Operating Profit
Highest at HKD 400.82 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at 37.35 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at HKD 257.47 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 226.95 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.62
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debtors Turnover Ratio
Highest at 6.54 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -6.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 93.09 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 93.09 MM has Grown at 12.84%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Footer loading
